Martha C. Cervantes-Rivera

Jal. CP 45110
Zapopan, JAL 45110, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

RETRACTED: Jarero-Basulto et al. Cytotoxic Effect of Amyloid-β1-42 Oligomers on Endoplasmic Reticulum and Golgi Apparatus Arrangement in SH-SY5Y Neuroblastoma Cells. NeuroSci 2024, 5, 141-157.

RETRACTED: Jarero-Basulto et al. Cytotoxic Effect of Amyloid-β1-42 Oligomers on Endoplasmic Reticulum and Golgi Apparatus Arrangement in SH-SY5Y Neuroblastoma Cells. NeuroSci 2024, 5, 141-157.

Journal: NeuroSci

Published: November 04, 2025

Evidence of a hormetic-like cytoprotective effect by erythropoietin in the SH-SY5Y cell model of oxygen-glucose deprivation.

Evidence of a hormetic-like cytoprotective effect by erythropoietin in the SH-SY5Y cell model of oxygen-glucose deprivation.

Journal: Neuroscience

Published: August 29, 2024

RETRACTED: Cytotoxic Effect of Amyloid-β1-42 Oligomers on Endoplasmic Reticulum and Golgi Apparatus Arrangement in SH-SY5Y Neuroblastoma Cells.

RETRACTED: Cytotoxic Effect of Amyloid-β1-42 Oligomers on Endoplasmic Reticulum and Golgi Apparatus Arrangement in SH-SY5Y Neuroblastoma Cells.

Journal: NeuroSci

Published: March 19, 2024

Intranasal erythropoietin protects granular cells and reduces astrogliosis in the dentate gyrus after ischemic damage, an effect associated with molecular changes in erythropoietin and its receptor.

Intranasal erythropoietin protects granular cells and reduces astrogliosis in the dentate gyrus after ischemic damage, an effect associated with molecular changes in erythropoietin and its receptor.

Journal: Neuroscience letters

Published: March 06, 2023

Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 11, 2020

New Aspects of VEGF, GABA, and Glutamate Signaling in the Neocortex of Human Temporal Lobe Pharmacoresistant Epilepsy Revealed by RT-qPCR Arrays.

New Aspects of VEGF, GABA, and Glutamate Signaling in the Neocortex of Human Temporal Lobe Pharmacoresistant Epilepsy Revealed by RT-qPCR Arrays.

Journal: Journal of molecular neuroscience : MN

Published: December 21, 2019

Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.

Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.

Journal: Current pharmaceutical design

Published: September 29, 2019

The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus.

The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus.

Journal: Frontiers in neuroscience

Published: November 16, 2018

Interactions Between Epilepsy and Plasticity.

Interactions Between Epilepsy and Plasticity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 24, 2017

Excitotoxicity triggered by neonatal monosodium glutamate treatment and blood-brain barrier function.

Excitotoxicity triggered by neonatal monosodium glutamate treatment and blood-brain barrier function.

Journal: Archives of medical research

Published: November 10, 2014

From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin.

From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin.

Journal: Frontiers in bioscience (Landmark edition)

Published: June 05, 2014

REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.

REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.

Journal: Life sciences

Published: April 14, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026